Live Broadcast to Explore A New Treatment Option Available for BTKi-Pretreated Patients with Mantle Cell Lymphoma

In an upcoming live broadcast, watch your peers provide an overview of the unmet needs in the treatment of patients with MCL who were previously treated with a BTKi. They will also discuss the efficacy and safety of a new treatment option for these patients, as well as explore patient cases to understand different treatment approaches for mantle cell lymphoma.

To obtain clinical expert insights and learn about how this therapy can impact your patients and your practice, watch the live broadcast on [BROADCAST DATE]. To register for the event, visit [REGISTRATION PAGE URL].

This program is sponsored by and the speaker is presenting on behalf of Lilly USA, LLC. It is being presented consistent with FDA guidelines and is not approved for continuing education credit.

© Lilly USA, LLC 2022. All rights reserved. PP-PT-US-0266